Prime Clinical Systems Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Prime Clinical Systems's estimated annual revenue is currently $3.9M per year.(i)
  • Prime Clinical Systems's estimated revenue per employee is $116,000

Employee Data

  • Prime Clinical Systems has 34 Employees.(i)

Prime Clinical Systems's People

NameTitleEmail/Phone
1
SW/Intellect Support ManagerReveal Email/Phone
2
TitlePCM SupportReveal Email/Phone
3
TrainingReveal Email/Phone
4
Implementation & TrainingReveal Email/Phone
5
AdministrationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M49-16%$46.4MN/A
#2
$9.1M72N/AN/AN/A
#3
$0.3M4N/AN/AN/A
#4
$2.1M21N/AN/AN/A
#5
$1M11N/AN/AN/A
#6
$44.5M29614%$23.6MN/A
#7
$20.5M76N/AN/AN/A
#8
$145.5M431N/AN/AN/A
#9
$2.4M24N/AN/AN/A
#10
$611.3M0N/A$186.6MN/A
#11
$12.6M52N/AN/AN/A
#12
$0.6M8N/AN/AN/A
#13
$8.7M67N/AN/AN/A
#14
$14.2M98N/AN/AN/A
#15
$3.6M31N/AN/AN/A
#16
$82.5M464-4%$19MN/A
#17
$1M11N/AN/AN/A
#18
$3.8M33N/AN/AN/A
#19
$59.3M32720%N/AN/A
#20
$2.1M13N/AN/AN/A
Add Company

What Is Prime Clinical Systems?

keywords:N/A

N/A

Total Funding

34

Number of Employees

$3.9M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Prime Clinical Systems News

2022-04-20 - Base edit your way to better crops

The methods are adaptations of the widely used CRISPR–Cas9 system, ... Like base editing, prime editing uses a modified Cas9 protein that...

2022-04-19 - E Clinical Trials Solutions Suite Technologies Market Size to ...

Moreover, the growing research and development expenditure on the development of drugs by pharma-biotech companies are the prime factors...

2022-03-22 - Sunitha Reddy, Prime Healthcare VP of Operations, Named to ...

Prime Healthcare is one of the nation's leading health systems with 45 ... will be a key to ensuring Prime's continued record of clinical,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.6M340%N/A
#2
$7.9M346%N/A
#3
$6M343%N/A
#4
$4.6M34N/AN/A
#5
$6M34-26%N/A